Lexiscan: Clinical Trials

3 trials of Lexiscan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Lexiscan: new trials by email Literature Review of Lexiscan trials Research Report on Lexiscan

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
Regadenoson, Placebo - Healthy Volunteers
Phase 1CompletedAstellas Pharma Global Development, Inc.362013-05-012013-08-30
Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia
adenosine, regadenoson - Coronary Artery Disease
Phase 1CompletedSt. Louis University462010-07-012017-06-23
Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Lexiscan - Sickle Cell Disease
Phase 1CompletedDana-Farber Cancer Institute392010-04-012014-03-07

Conditions studied

Anemia, Sickle Cell (1)  ·  Coronary Artery Disease (1)

Sponsors

Astellas Pharma Global Development, Inc. (1)  ·  Dana-Farber Cancer Institute (1)  ·  St. Louis University (1)

Countries

United States (3)

Top investigators

David Nathan, MD (1)  ·  Michael J Lim, MD (1)

Results publications

PMID 23377438, PMID 26242981, PMID 26607361

NIH funding

1RC2HL101367-01 (1)